Replay available

Arcutis Biotherapeutics, Inc. (ARQT) Q3 2025 Earnings Call

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.

Tue, October 28, 2025 at 10:30 AMendedReplay
Arcutis Biotherapeutics, Inc. (ARQT) Q3 2025 Earnings Call

Hosted by

Featured presenters

Brian Shawcoff

Head of Investor Relations

Frank Watanabe

President and CEO

Todd Edwards

Chief Commercial Officer

Latha Varavan

Chief Financial Officer

Patrick Burnett

Chief Medical Officer

Douglas DeRuggiero

Certified Physician Assistant and Doctor of Medical Science

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcutis Biotherapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.957 Good day, and thank you for standing by. Welcome to the Arcudous Biotherapeutics 00:00:05.957 -- 00:00:11.563 2025 Third Quarter Financial Results and Investor Day presentation. 00:00:11.563 -- 00:00:15.327 At this time, all participants are in a listen-only mode. 00:00:15.327 -- 00:00:20.272 After the speaker's presentation, there will be a question and answer session. 00:00:20.272 -- 00:00:25.117 To submit questions, please use the question submission field located at the bottom of 00:00:25.117 -- 00:00:27.503 your webcast interface. 00:00:27.503 -- 00:00:31.467 Please be advised that today's conference is being recorded. 00:00:31.467 -- 00:00:36.432 I would now like to hand the conference over to your first speaker today, Brian Shawcoff, 00:00:36.432 -- 00:00:39.172 Head of Investor Relations. 00:00:39.314 -- 00:00:40.435 Please go ahead. 00:00:40.435 -- 00:00:44.639 Thank you. Good morning, everyone. And thank you for joining us today to review our third 00:00:44.639 -- 00:00:48.483 quarter 2025 financial results and business update. 00:00:48.483 -- 00:00:51.226 And for our extended investor day presentation. 00:00:51.226 -- 00:00:56.478 Slides for today's call are available in the investor section of the Arcutus website. 00:00:56.478 -- 00:01:01.624 Joining me on the call today are Frank Watanabe, President and CEO of Arcutis, 00:01:01.624 -- 00:01:06.750 Todd Edwards, Chief Commercial Officer, Patrick Burnett, Chief Medical Officer, 00:01:06.750 -- 00:01:10.073 and Mata Varavan, Chief Financial Officer. 00:01:10.073 -- 00:01:14.939 We will also be joined later in the call by Douglas DeRiggiero, a Certified Physician 00:01:14.939 -- 00:01:19.544 Assistant and Doctor of Medical Science who has specialized in dermatology for the...